This indicates that, in the examined astrocytoma model, CAPE does not act per se but functions as a modulator of cell responses to inflammatory stimuli, as further analyzed in subsequent experiments. This evidence concerns the gene SMC2 and astrocytoma (excluding glioblastoma).